Vectura News

Discover more about our company, science, innovation and people with the latest headlines from Vectura.

Displaying 12 of 68

Vectura Fertin Pharma, Inc., a Subsidiary of Philip Morris International, Announces Agreement for Sale of Vectura Group to Molex

Published17/09/2024

Mundipharma and Vectura announce plans to reformulate flutiform®

Published16/04/2024

£58m Inhalation Centre of Excellence granted planning permission

Published27/09/2022

Executive Changes at Vectura

Published31/03/2022

Vectura wins Mediscience’s Best Communication Award

Published17/11/2021

Our CDMO expertise in the spotlight

Published24/08/2021

Vectura at CPhI North America 2021: July 26 – August 6

Published26/07/2021

Vectura Signs Pre-Clinical Development Agreement with Incannex to Advance IHL-216A for the Treatment of Traumatic Brain Injury

Published22/06/2021

Shortlisted for Best Sustainability Reporting: Healthcare

Published15/06/2021

Vectura announces completion of management buy-out of Lyon oral subsidiary, Skyepharma Production SAS

Published10/06/2021

Vectura at BIO Digital, June 10-11 & 14-18, 2021

Published09/06/2021

Vectura and Inspira Pharmaceuticals Sign Agreement to Develop Potential Inhaled Treatment for COVID-19

Published06/05/2021

Displaying 12 of 68